They are in a class of drugs known as incretin mimetics. GLP-1 drugs are more commonly known by their brand names like Ozempic, Wegovy (semaglutide), Mounjaro (tirzepatide), and Victoza (liraglutide).

In April 2005, the FDA approved the first GLP1 analogue, exenatide (Byetta ... and side-effect profile. Liraglutide, an acylated GLP1 analogue that requires daily dosing, is another incretin ...